3360-85-8

Basic information

• Product Name: N-ethyl-(4-methoxy-2-nitrophenyl)amine
• Synonyms: N-ethyl-(4-methoxy-2-nitrophenyl)amine
• CAS NO: 3360-85-8
• Molecular Weight: 196.206
• Mol File: 3360-85-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: N-ethyl-(4-methoxy-2-nitrophenyl)amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-ethyl-(4-methoxy-2-nitrophenyl)amine(3360-85-8)
• EPA Substance Registry System: N-ethyl-(4-methoxy-2-nitrophenyl)amine(3360-85-8)

Safety Data

• Hazardous Substances Data: 3360-85-8(Hazardous Substances Data)

Upstream product

• 75-07-0 acetaldehyde 
• 96-96-8 4-methoxy-2-nitroaniline 
• 109475-48-1 benzenesulfonic acid-(N-ethyl-4-methoxy-2-nitro-anilide) 
• 75-04-7 ethylamine 
• 61324-93-4 1-fluoro-nitro-4-methoxybenzene 
• 109-89-7 diethylamine 
• 10298-80-3 2-chloro-5-methoxynitrobenzene 
• 5464-08-4 N-(4-methoxy-2-nitrophenyl)benzenesulfonamide 

Downstream Products

• 99168-12-4 1-ethyl-5-methoxy-1H-benzimidazol-2-ylamine 
• 102026-69-7 (1-ethyl-5-methoxy-1H-benzimidazol-2-yl)-(4-nitro-benzyliden)-amine 
• 218143-47-6 bispyridine-2,6-dicarboxamide 
• 79938-40-2 1-ethyl-5-methoxybenzimidazole 
• 79938-45-7 4-methoxy-N¹-ethylbenzene-1,2-diamine 

Relevant articles and documents

Development of a Selective Inhibitor of Protein Arginine Deiminase 2

Protein arginine deiminase 2 (PAD2) plays a key role in the onset and progression of multiple sclerosis, rheumatoid arthritis, and breast cancer. To date, no PAD2-selective inhibitor has been developed. Such a compound will be critical for elucidating the

Bent tridentate receptors in calamitic mesophases with predetermined photophysical properties: New luminescent lanthanide-containing materials

A new synthetic strategy has been developed to introduce bent and rigid tridentate 2,6-bis(benzimidazol-2'-yl)pyridine cores into rodlike ligands L(11-17). The crystal structure of the nonmesogenic ligand L13 (C39H37N5O4, triclinic, P1, Z = 2) shows the expected trans-trans conformation of the tridentate binding unit, which provides a linear arrangement of the semirigid aromatic sidearms. The crystal structure of the related mesogenic ligand L16 (C61H81N5O4, triclinic, P1, Z = 2) demonstrates the fully extended conformation adopted by the lipophilic side chains, leading to a slightly helically twisted I-shaped molecule. A rich and varied mesomorphism results which can be combined with the simultaneous tuning of electronic and photophysical properties via a judicious choice of the spacers between the rigid central core and the semirigid lipophilic sidearms. Ligands L13,14 react with Ln(NO3)3·χH2O to give quantitatively and selectively the neutral 1:1 complexes [Ln(L')(NO3)3] (Ln = La to Lu), which are stable in the solid state at room temperature but partially dissociate in acetonitrile to give the cationic species [Ln(L')(NO3)2]+. The crystal structure of [Lu-(L13)(NO3)3]·3CH3CN (30, LUC45H46N11O13, monoclinic, C2/c, Z = 8) reveals a U-shaped arrangement of the ligand strand arising from the cis-cis conformation of the coordinated tridentate binding unit. This drastic geometric change strongly affects the thermal behavior and the photophysical and electronic properties of the lipophilic complexes [Ln(L14)(NO3)3]. Particular attention has been focused on structure-properties relationships, which can be modulated by the size of the lanthanide metal ions.

Bicyclic compounds with potential antiulcer and/or antisecretory activity. I - 4,5,6,7-tetrahydrobenzimidazoles

-